A multivariate generalized linear model of the effect of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 in end-stage renal disease
References
- Mohammed RB, Mohammed MM. Potential role of niacin as adjuvant to sevelamer on serum levels of inorganic phosphorus, calcium and calcium-phosphorus product in hemodialysis patients with hyperphosphatemia. Res J Pharm Tech. 2022;15(5):2158-62.
- Braun MM, Khayat M. Kidney disease: End-stage renal disease. FP Essent. 2021;509:26-32.
- Rocha AD, Garcia S, Santos AB, Eduardo JCC, Mesquita CT, Lugon JR, et al. No race-ethnicity adjustment in CKD-EPI equations is required for estimating glomerular filtration rate in the Brazilian population. Int J Nephrol. 2020;2020:2141038.
- Oweis AO, Al-Qarqaz F, Bodoor K, Heis L, Alfaqih MA, Almomani R, et al. Elevated interleukin 31 serum levels in hemodialysis patients are associated with uremic pruritus. Cytokine. 2021;138:155369.
- Dizdar OS, Yıldız A, Gul CB, Gunal AI, Ersoy A, Gundogan K. The effect of hemodialysis, peritoneal dialysis and renal transplantation on nutritional status and serum micronutrient levels in patients with end-stage renal disease; Multicenter, 6-month period, longitudinal study. J Trace Elem Med Biol. 2020;60:126498.
- Song YR, Kim JK, Lee HS, Kim SG, Choi EK. Serum levels of protein carbonyl, a marker of oxidative stress, are associated with overhydration, sarcopenia and mortality in hemodialysis patients. BMC Nephrol. 2020;21(1):281.
- Ravarotto V, Simioni F, Pagnin E, Davis PA, Calò LAJLs. Oxidative stress – chronic kidney disease – cardiovascular disease: A vicious circle. Life Sci. 2018;210:125-31.
- Zemaitis MR, Foris LA, Katta S, Bashir K. Uremia. Treasure Island (FL): StatPearls Publishing; 2024.
- Naber T, Purohit S. Chronic Kidney Disease: Role of Diet for a Reduction in the severity of the disease. Nutrients. 2021;13(9):3277.
- Block GA, Ix JH, Ketteler M, Martin KJ, Thadhani RI, Tonelli M, et al. Phosphate homeostasis in CKD: report of a scientific symposium sponsored by the National Kidney Foundation. Am J Kidney Dis. 2013;62(3):457-73.
- Heaney RP. Vitamin D in health and disease. Clin J Am Soc Nephrol. 2008;3(5):1535-41.
- Wani N, Pasha T. Laboratory tests of renal function. Anaesth Intens Care Med. 2021;22(7):393-7.
- Maraj M, Hetwer P, Dumnicka P, Ceranowicz P, Mazur-Laskowska M, Zabek-Adamska A, et al. Acute phase proteins and vitamin D seasonal variation in end-stage renal disease patients. J Clin Med. 2020;9(3):807.
- Bassiouni W, Ali MA, Schulz R. Multifunctional intracellular matrix metalloproteinases: implications in disease. FEBS J. 2021; 288(24):7162-82.
- Bjerkeli V, Halvorsen B, Damås J, Nordøy I, Yndestad A, Aukrust P, et al. Expression of matrix metalloproteinases in patients with Wegener’s granulomatosis. Ann Rheum Dis. 2004;63(12):1659-63.
- Zakiyanov O, Kalousová M, Zima T, Tesař V. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease. Adv Clin Chem. 2021;105:141-212.
- Suzuki D, Miyazaki M, Jinde K, Koji T, Yagame M, Endoh M, et al. In situ hybridization studies of matrix metalloproteinase-3, tissue inhibitor of metalloproteinase-1 and type IV collagen in diabetic nephropathy. Kidney Int. 1997;52(1):111-9.
- Martins VL, Caley M, O’Toole EA. Matrix metalloproteinases and epidermal wound repair. Cell Tissue Res. 2013;351(2):255-68.
- Gomez D, Alonso D, Yoshiji H, Thorgeirsson U. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions. Eur J Cell Biol. 1997;74(2):111-22.
- Martin DC, Sanchez-Sweatman OH, Ho A, Inderdeo DS, Tsao M-S, Khokha R. Transgenic TIMP-1 inhibits simian virus 40 T antigen-induced hepatocarcinogenesis by impairment of hepatocellular proliferation and tumor angiogenesis. Lab Invest. 1999;79(2):225-34.
- Kanauchi M, Nishioka H, Nakashima Y, Hashimoto T, Dohi K. Role of tissue inhibitors of metalloproteinase in diabetic nephropathy. Nihon Jinzo Gakkai Shi. 1996;38(3):124-8.
- Carome M, Striker L, Peten E, Moore J, Yang C, Stetler-Stevenson W, et al. Human glomeruli express TIMP-1 mRNA and TIMP-2 protein and mRNA. Am J Physiol. 1993;264(6):F923-F9.
- Kökény G, Németh Á, Kopp JB, Chen W, Oler AJ, Manzéger A, et al. Susceptibility to kidney fibrosis in mice is associated with early growth response-2 protein and tissue inhibitor of metalloproteinase-1 expression. Kidney Int. 2022;102(2):337-54.
- Mora-Gutiérrez JM, Rodríguez JA, Fernández-Seara MA, Orbe J, Escalada FJ, Soler MJ, et al. MMP-10 is increased in early stage diabetic kidney disease and can be reduced by renin-angiotensin system blockade. Sci Rep. 2020;10(1):1-12.
- 25. Levey AS, Coresh J, Greene T, Marsh J, Stevens LA, Kusek JW, et al. Expressing the Modification of Diet in Renal Disease Study equation for estimating glomerular filtration rate with standardized serum creatinine values. Clin Chem. 2007;53(4):766-72.
- Mateu-de Antonio JJMP, Practice. New predictive equations for serum ionized calcium in hospitalized patients. Med Princ Pract. 2016;25(3):219-26.
- Koch SM, Warters RD, Mehlhorn U. The simultaneous measurement of ionized and total calcium and ionized and total magnesium in intensive care unit patients. J Crit Care. 2002;17(3):203-5.
- Velasquez-Mao AJ, Velasquez MA, Hui Z, Armas-Ayon D, Wang J, Vandsburger MH. Hemodialysis exacerbates proteolytic imbalance and pro-fibrotic platelet dysfunction. Sci Rep. 2021;11(1):11764.
- Ishizaki M, Matsunaga T, Adachi K, Miyashita E. Serum matrix metalloproteinase-3 in hemodialysis patients with dialysis-related amyloidosis. Hemodialysis Int. 2004;8(3):219-25.
- Musiał K, Zwolińska D. Neutrophil gelatinase-associated lipocalin (NGAL) and matrix metalloproteinases as novel stress markers in children and young adults on chronic dialysis. Cell Stress Chaperones. 2011;16(2):163-71.
- Preston GA, Barrett CV, Alcorta DA, Hogan SL, Dinwiddie L, Jennette JC, et al. Serum Matrix Metalloproteinases MMP-2 and MMP-3 levels in dialysis patients vary independently of CRP and IL-6 Levels. Nephron. 2002;92(4):817-23.
- Pawlak K, Pawlak D, Mysliwiec M. Circulating β-chemokines and matrix metalloproteinase-9/tissue inhibitor of metalloproteinase-1 system in hemodialyzed patients–Role of oxidative stress. Cytokine. 2005;31(1):18-24.
- Tan RJ, Liu Y. Matrix metalloproteinases in kidney homeostasis and diseases. Am J Physiol Renal Physiol. 2012;302(11):F1351-61.
- Fouque D, Roth H, Darne B, Bouchet JL, Daugas E, Drueke TB, et al. Achievement of 2009 and 2017 Kidney Disease: Improving Global Outcomes mineral and bone targets and survival in a French cohort of chronic kidney disease Stages 4 and 5 non-dialysis patients. Clin Kidney J. 2018;11(5):710-9.
- Rastogi A, Bhatt N, Rossetti S, Beto J. Management of Hyperphosphatemia in End-Stage Renal Disease: A New Paradigm. J Ren Nutr. 2021;31(1):21-34.
- Garabed E, Norbert L, Bertram L. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Update Work Group. KDIGO 2017 Clinical practice guideline update for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease–mineral and bone disorder (CKD-MBD). Kidney Int Suppl. 2017;7(1):1-59.
- Crespo-Salgado J, Vehaskari VM, Stewart T, Ferris M, Zhang Q, Wang G, et al. Intestinal microbiota in pediatric patients with end stage renal disease: a midwest pediatric nephrology consortium study. Microbiome. 2016;4(1):50.
- Laville SM, Couturier A, Lambert O, Metzger M, Mansencal N, Jacquelinet C, et al. Urea levels and cardiovascular disease in patients with chronic kidney disease. Nephrol Dial Transplant. 2022;38(1):184-92.
- Russo E, Viazzi F, Pontremoli R, Barbagallo CM, Bombelli M, Casiglia E, et al. Association of uric acid with kidney function and albuminuria: the Uric Acid Right for heArt Health (URRAH) Project. J Nephrol. 2021:1-11.
- Cirillo M, Laurenzi M, Mancini M, Zanchetti A, Lombardi C, De Santo NG. Low glomerular filtration in the population: prevalence, associated disorders, and awareness. Kidney Int. 2006; 70(4):800-6.
- Beto J, Bhatt N, Gerbeling T, Patel C, Drayer D. Overview of the 2017 KDIGO CKD-MBD update: practice implications for adult hemodialysis patients. J Ren Nutr. 2019;29(1):2-15.
- Goodman WG, editor The consequences of uncontrolled secondary hyperparathyroidism and its treatment in chronic kidney disease. Seminars in dialysis; 2004: Wiley Online Library.
- Liu H, Wang R. Associations between the serum magnesium and all-cause or cardiovascular mortality in chronic kidney disease and end-stage renal disease patients: A meta-analysis. Medicine. 2021;100(45).
- Palumbo VD, Palumbo VD, Damiano G, Messina M, Fazzotta S, Lo Monte G, et al. Tertiary hyperparathyroidism: a review. Clin Ter. 2021;172(3):241-6.
- Rymarz A, Mosakowska M, Niemczyk S. The significance of metalloproteinase 3 (MMP-3), chemokine CXC ligand 13 (CXCL-13) and complement component C5a in different stages of ANCA associated vasculitis. Sci Rep. 2021;11(1):5132.
- Ozkan H, Okuturlar Y, Kocoglu H, Hursitoglu M, Gedikbasi A, Utku IK, et al. Serum levels and urinary excretion of tenascin-C and TIMP-1 in acute kidney injury. Clin Lab. 2019;65(10).
- Lieb W, Song RJ, Xanthakis V, Vasan RS. Association of circulating tissue inhibitor of metalloproteinases-1 and procollagen type III aminoterminal peptide levels with incident heart failure and chronic kidney disease. J Am Heart Assoc. 2019;8(7):e011426.
- Caimi G, Hopps E, Montana M, Urso C, Carollo C, Canino B, et al. The function of matrix metalloproteinase-9 (MMP-9) and its tissue inhibitor (TIMP-1) in several clinical conditions: Results and analysis of our survey. J Clin Hematol Microcirc. 2021;78(4):401-16.
- Won AJ, Kim S, Kim YG, Kim KB, Choi WS, Kacew S, et al. Discovery of urinary metabolomic biomarkers for early detection of acute kidney injury. Mol Biosyst. 2016;12(1):133-44.
- Atamaniuk J, Kopecky C, Skoupy S, Saemann MD, Weichhart T. Apoptotic cell-free DNA promotes inflammation in haemodialysis patients. Nephrol Dial Transplant. 2012;27(3):902-5.
Language: English
Page range: 69 - 74
Submitted on: May 15, 2023
Accepted on: Jun 9, 2023
Published online: Jul 10, 2024
Published in print: Jun 1, 2024
Published by: Sciendo
In partnership with: Paradigm Publishing Services
Related subjects:
© 2024 Asawer Hassan Najm, Habiba Khdair Abdalsada, Shatha Rouf Moustafa, Hussein Kadhem Al-Hakeim, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.